Variable | No anticancer treatment last 30 days n = 174 | Anticancer treatment given last 30 days n = 73 | P value a | ||
---|---|---|---|---|---|
n | % | n | % | ||
Age (years) - median (min - max) | 72 | (18–93) | 74 | (40–91) | NS |
Length of stay (days) - median (min - max) | 8 | (0–84) | 12 | (0–68) | 0.03 |
Gender | Â | Â | Â | Â | NS |
 Female | 68 | 39% | 28 | 38% |  |
 Male | 106 | 61% | 45 | 62% |  |
Hospital |  |  |  |  | < 0.01 |
 District Hospital Lofoten | 27 | 16% | 6 | 8% |  |
 District Hospital Vesterålen | 47 | 27% | 11 | 15% |  |
 Central Hospital Bodø | 100 | 57% | 56 | 77% |  |
Department | Â | Â | Â | Â | NS |
 Internal medicine | 76 | 44% | 44 | 60% |  |
 Surgery | 91 | 52% | 25 | 34% |  |
 Others | 7 | 4% | 4 | 6% |  |
Primary malignancy | Â | Â | Â | Â | 0.02 |
 Upper gastrointestinal | 34 | 20% | 5 | 7% |  |
 Colorectal | 27 | 15% | 4 | 5% |  |
 Lung | 38 | 22% | 21 | 29% |  |
 Breast | 7 | 4% | 4 | 5% |  |
 Gynaecological | 5 | 3% | 2 | 3% |  |
 Urological | 8 | 5% | 6 | 8% |  |
 Male genitalia | 11 | 6% | 4 | 5% |  |
 Haematological and lymphoma | 17 | 10% | 22 | 30% |  |
 Unknown origin | 15 | 8% | 2 | 3% |  |
 Other b | 12 | 7% | 3 | 4% |  |
Treatment intent |  |  |  |  | < 0.001 |
 Palliative | 135 | 78% | 67 | 92% |  |
 Curative | 2 | 1% | 3 | 4% |  |
 Diagnostic | 37 | 21% | 3 | 4% |  |
Anticancer treatment |  |  |  |  | < 0.001 |
 Systemic treatment | 64 | 37% | 52 | 71% |  |
 Radiotherapy | 5 | 3% | 14 | 19% |  |
 Surgery | 5 | 3% | 7 | 10% |  |
 No treatment | 100 | 57% | 0 | 0% |  |
Specialist palliative care | Â | Â | Â | Â | NS |
  > 30 days before death | 33 | 19% | 11 | 15% |  |
  < 30 days before death | 32 | 18% | 14 | 19% |  |
 Not involved | 109 | 63% | 48 | 66% |  |